Article
NGFR-driven suppression of antigen presentation limits CD8+ T cell immunity and response to checkpoint blockade
2026-08-25
Abstract excerpt
Immune checkpoint blockade has revolutionized cancer therapy; however, numerous tumors remain resistant by adopting cellular states that impede immune recognition. In this study, we identify the nerve growth factor receptor (NGFR) as a regulator of immune evasion in head and neck squamous cell carcinoma (HNSCC). Genetic ablation of Ngfr resulted in impaired tumor growth in immunocompetent MOC2 HNSCC, while pharmac...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2fb1c185-d229-51f3-9ad9-34549603bd37
- DOI
- 10.64898/2026.08.24.746602
